These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 5941428)

  • 1. Excretion of phenolic amines by patients with cirrhosis of the liver.
    Dubovský J; Petrásek J
    Rev Czech Med; 1966; 12(2):98-102. PubMed ID: 5941428
    [No Abstract]   [Full Text] [Related]  

  • 2. [Excretion of phenolic amines by patients with liver cirrhosis].
    Dubovský J; Petrásek J
    Cas Lek Cesk; 1965 Oct; 104(43):1183-5. PubMed ID: 5851899
    [No Abstract]   [Full Text] [Related]  

  • 3. [Metabolism of phenolic compounds in liver diseases with encephalopathic manifestations].
    Ruge W; Otto P
    Verh Dtsch Ges Inn Med; 1969; 75():329-32. PubMed ID: 5400793
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemical relations between phenolic and nitrogenous compounds in plants: some biological implications.
    Synge RL
    Hoppe Seylers Z Physiol Chem; 1972 Feb; 353(2):128-9. PubMed ID: 5027689
    [No Abstract]   [Full Text] [Related]  

  • 5. [Significance in the determination of total and free phenols in acute hepatitis and liver cirrhosis].
    Davcev P; Hrisoho R; Vanovski B; Popstefanova A; Bidikov V
    God Zb Med Fak Skopje; 1974; 20():59-72. PubMed ID: 4465266
    [No Abstract]   [Full Text] [Related]  

  • 6. Perinatal development of amine, alcohol and phenol sulfoconjugations in the rat.
    Iwasaki K; Shiraga T; Takeshita K; Katashima M; Nagase K; Tada K; Noda K; Noguchi H
    Res Commun Chem Pathol Pharmacol; 1993 Aug; 81(2):183-90. PubMed ID: 8210697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased thromboxane metabolites excretion in liver cirrhosis.
    Davì G; Ferro D; Basili S; Iuliano L; Camastra C; Giammarresi C; Santarone S; Rocca B; Landolfi R; Ciabattoni G; Cordova C; Violi F
    Thromb Haemost; 1998 Apr; 79(4):747-51. PubMed ID: 9569186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous nitric oxide production is augmented as the severity advances in patients with liver cirrhosis.
    Hori N; Okanoue T; Mori T; Kashima K; Nishimura M; Nanbu A; Yoshimura M; Takahashi H
    Clin Exp Pharmacol Physiol; 1996 Jan; 23(1):30-5. PubMed ID: 8713493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of liver function tests as predictors of rifampicin metabolism in cirrhosis.
    McConnell JB; Powell-Jackson PR; Davis M; Williams R
    Q J Med; 1981; 50(197):77-82. PubMed ID: 7267969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carnitine metabolism in patients with chronic liver disease.
    Krähenbühl S; Reichen J
    Hepatology; 1997 Jan; 25(1):148-53. PubMed ID: 8985281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced renal clearance of uric acid in hepatic cirrhosis.
    Higuchi T; Nakamura T; Uchino H
    Isr J Med Sci; 1981 Nov; 17(11):1015-8. PubMed ID: 7319788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-hepatic disposition relationships for phenolic compounds.
    Mellick GD; Roberts MS
    Toxicol Appl Pharmacol; 1999 Jul; 158(1):50-60. PubMed ID: 10387932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of nicotinic acid and its amides on urinary excretion of products damaging König, Roggen and Huff reactions in liver cirrhosis].
    DIOGUARDI N
    Riv Gastroenterol; 1951; 3(6):205-12. PubMed ID: 14900852
    [No Abstract]   [Full Text] [Related]  

  • 14. [Metabolic heterogeneity of glycogen in hepatocytes of patients with liver cirrhosis].
    Kudriavtseva MV; Bezborodkina NN; Radchenko VG; Okovityĭ SV; Ivanova OV; Kudriavtsev BN
    Tsitologiia; 2000; 42(6):550-5. PubMed ID: 10953859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathogenesis of hepatic coma].
    Capocaccia L; Rossi Fanelli F; Cascino A; Cangiano C; Calcaterra V; de Conciliis D; Gentile S; Merli M; Riggio O; Stortoni M; Giunchi G
    Recenti Prog Med; 1981 Apr; 70(4):358-99. PubMed ID: 6114522
    [No Abstract]   [Full Text] [Related]  

  • 16. Urinary sodium balance in patients with cirrhosis: relationship to quantitative parameters of liver function.
    Wensing G; Lotterer E; Link I; Hahn EG; Fleig WE
    Hepatology; 1997 Nov; 26(5):1149-55. PubMed ID: 9362355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The metabolism of riboflavin in female patients with liver cirrhosis.
    Zempleni J; Galloway JR; McCormick DB
    Int J Vitam Nutr Res; 1996; 66(3):237-43. PubMed ID: 8899458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The absorption and excretion of tocopherol in Laennec's cirrhosis.
    KLATSKIN G; MOLANDER DW
    J Clin Invest; 1952 Feb; 31(2):159-70. PubMed ID: 14907894
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanisms of disturbed renal water excretion in cirrhosis.
    Schrier RW
    Gastroenterology; 1983 Apr; 84(4):870-2. PubMed ID: 6825997
    [No Abstract]   [Full Text] [Related]  

  • 20. [Study of the relation of urinary excretion of potassium and sodium in ascitic cirrhosis].
    Vivien P; Gastard J; Loussouarn J; Saint-Drenant P; Cousin P
    Therapie; 1967; 22(1):177-89. PubMed ID: 6082052
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.